Design and Evaluation of Chitosan‐Coated Liposomal Microneedle Capsules for Oral Insulin Delivery: A Proof of Concept
Macromolecular Bioscience · 2026
DOI: 10.1002/mabi.202500661 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, 2026. Verfasst von Kirthana Gopal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Chitosan, Insulin, Liposomes, Drug Delivery Systems. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: Ministry of Higher Education, Fundamental Research Grant Scheme, Universiti Malaya-Grant Research Program-Research Cluster.
Abstract (Originalsprache)
The study presents a proof‐of‐concept for novel protein drug delivery system by formulating layer‐coated liposomes with chitosan oligosaccharide (COS) and insulin, infused in dissolvable microneedles (DMNs), and packed in an enteric‐coated capsule for oral delivery of insulin. Cellular uptake studies using CCD841 showed time‐dependent internalization, while cytotoxicity assays confirmed over 80% cell viability, indicating biocompatibility. The fabricated hydroxypropyl methylcellulose (HPMC) and Aloe vera (AV) based DMN had a pyramidal shape with a height of 464.25 ± 1.48 µm. Permeability studies revealed a sustained release profile in SIF for both layer‐coated liposomes (80.08% ± 3.02) and DMN‐containing layer‐coated liposomes (75.06% ± 1.06). In contrast, a burst release in SGF for layer‐coated liposomes and for DMNs is attributed to charge interactions and polymer solubility. Enteric‐coated capsules demonstrated no insulin release in SGF for 1 h, indicating effective gastric protection. The release for an enteric‐coated capsule containing DMN infused with layer‐coated liposomes in SIF reached 79.24% ± 1.22, mirroring the release profile of DMNs. This multilayered system effectively protects insulin from gastric degradation, facilitates delivery of insulin to the intestine, and achieves a sustained release profile, offering a promising strategy for oral insulin delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia.
- Universiti Malaya-Research Centre for Biopharmaceuticals and Advanced Therapeutics (UBAT), Department of Pharmacology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
- Bioactive Resources for Innovative Clinical Applications research unit and Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
- The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.
- Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand.
- Centre of Advanced Materials (CAM), Faculty of Engineering, Universiti Malaya, Kuala Lumpur, Malaysia.
ORCID-Profile: Syed Mahmood
Förderung
- Ministry of Higher Education
- Fundamental Research Grant Scheme
- Universiti Malaya-Grant Research Program-Research Cluster
Zitieren
APA
Gopal, K., Chellathurai, M. S., Sofian, Z. M., Aramwit, P., & Mahmood, S. (2026). Design and Evaluation of Chitosan‐Coated Liposomal Microneedle Capsules for Oral Insulin Delivery: A Proof of Concept. Macromolecular Bioscience. https://doi.org/10.1002/mabi.202500661
Vancouver
Gopal K, Chellathurai MS, Sofian ZM, Aramwit P, Mahmood S. Design and Evaluation of Chitosan‐Coated Liposomal Microneedle Capsules for Oral Insulin Delivery: A Proof of Concept. Macromolecular Bioscience. 2026. doi:10.1002/mabi.202500661
BibTeX
@article{Gopal2026,
author = {Gopal, Kirthana and Chellathurai, Melbha Starlin and Sofian, Zarif Mohamed and Aramwit, Pornanong and Mahmood, Syed},
title = {Design and Evaluation of Chitosan‐Coated Liposomal Microneedle Capsules for Oral Insulin Delivery: A Proof of Concept},
journal = {Macromolecular Bioscience},
year = {2026},
doi = {10.1002/mabi.202500661}
}
EUVIMED